Can pregnant patients take Apremilast?

For pregnant patients, the drug needs to be used with great caution because it may have potential effects on the fetus. For Apremilast (Apremilast), there is insufficient clinical data to ensure its safety in pregnant women. Therefore, in most cases, doctors do not recommend taking Apremilast during pregnancy.

The drug properties of apremilast and its effects on pregnant women and fetuses have not been fully established in large-scale human studies. However, animal studies suggest that high doses of Apremilast may adversely affect embryonic development, leading to embryonic malformations and fetal death. While these results don't necessarily apply to humans, the potential risk is enough to cause concern and lead doctors to avoid using the drug during pregnancy.

If a pregnant patient is taking Apremilast and discovers that she is pregnant, she should tell her doctor immediately. The doctor will consider stopping or adjusting the drug treatment plan based on the patient's specific situation and disease assessment. In some cases, if the mother's disease is severe and uncontrollable, the doctor may decide to continue using Apremilast while closely monitoring the patient's health and fetal development.

In general, the use of Apremilast (apmilast) should be avoided during pregnancy, especially in the first trimester, the first trimester. If you are taking Apremilast before or during pregnancy, you should consult your doctor promptly and follow your doctor's recommendations. Doctors will consider the risks and benefits to develop the most appropriate treatment plan to ensure the health of mother and baby.